Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Sugi Holdings Co ( (JP:7649) ) is now available.
In August 2025, Sugi Holdings Co. reported a 2.4% increase in sales for existing stores, driven by a 1.4% rise in the drugstore segment and a 6.1% boost in the prescription business. On an all-store basis, total sales surged by 13.9%, with the drugstore business growing by 4.9% and the prescription business by an impressive 48.5%. The company opened nine new stores and closed four, bringing the total number of outlets to 2,279 by the end of the month. These developments indicate a strong market position and growth trajectory for Sugi Holdings, likely benefiting stakeholders and enhancing its competitive edge in the industry.
The most recent analyst rating on (JP:7649) stock is a Buy with a Yen4300.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.
More about Sugi Holdings Co
Sugi Holdings Co. operates in the pharmaceutical and retail industry, primarily focusing on drugstore and prescription businesses through its Sugi Pharmacy and Hanshin Dispensing units. The company targets the Japanese market with a network of stores offering a range of pharmaceutical products and services.
Average Trading Volume: 597,403
Technical Sentiment Signal: Buy
Current Market Cap: Yen726.4B
See more data about 7649 stock on TipRanks’ Stock Analysis page.